Cargando…
Review of oral oxymorphone in the management of pain
Chronic cancer and nonmalignant pain (CNMP) is a common and major health problem afflicting approximately 40 million persons in the US. Most cancer patients, and many patients with CNMP, require opioid analgesics to obtain adequate pain relief. Oral oxymorphone is a new formulation of an existing pa...
Autor principal: | Sloan, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621383/ https://www.ncbi.nlm.nih.gov/pubmed/19209260 |
Ejemplares similares
-
Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release
por: Benedek, Irma H, et al.
Publicado: (2011) -
Efficacy of systemic HS-198, an analogue of oxymorphone, on cancer pain-related behaviour in mice
por: Asim, Muhammad F, et al.
Publicado: (2011) -
A Comparison of Daily Average Consumption (DACON) of Oxycodone and Oxymorphone Long-Acting Oral Tablets
por: Rubino, Mark, et al.
Publicado: (2011) -
Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers
por: Coyle, D. Tyler, et al.
Publicado: (2020) -
Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015
por: Conrad, Caitlin, et al.
Publicado: (2015)